MoneyWorks4Me

Cadila Healthcare informs about press release

03 Feb 2020 Evaluate

Cadila Healthcare has informed that the company has enclosed a copy of press release dated February 3, 2020 titled ‘Zydus receives approval from DCGI for Saroglitazar Magnesium for treatment of Type II Diabetes.’ The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..